Heron Therapeutics Inc (NASDAQ:HRTX)

31.00
Delayed Data
As of May 23
 -0.60 / -1.90%
Today’s Change
12.70
Today|||52-Week Range
34.00
+71.27%
Year-to-Date

Today’s Trading

Previous close31.60
Today’s open31.40
Day’s range30.80 - 32.17
Volume602,548
Average volume (3 months)1,208,103
Market cap$2.3B
Data as of 4:00pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)+20.05%
Earnings growth (this year)+32.29%
Earnings growth (next 5 years)+18.90%
Revenue growth (last year)+2,305.55%
P/E ratioNM
Price/Sales31.79
Price/Book15.99

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...0.000.00%
ACORAcorda Therapeutics ...+0.10+0.43%
ATNXAthenex Inc-0.09-0.53%
BYSIBeyondspring Inc-3.47-11.20%
Data as of 4:00pm ET, 05/23/2018

Financials

Next reporting dateAugust 6, 2018
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$30.8M
Annual profit (last year)-$197.5M
Net profit margin-641.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
San Diego, California

Forecasts